# Validation Summary

## Snapshot

- Date: 2026-05-06
- Scope: MVP prototype repository review
- Status: demo-ready for internal and partner walkthroughs, not pilot-ready
- Data basis: synthetic demo records only
- Scoring basis: deterministic mock scoring rules only

## Purpose

This summary records what has actually been reviewed in the current MVP and what remains unvalidated. It should not be interpreted as clinical evidence.

## Evidence Reviewed

- backend API tests for health checks, schema validation, demo data seeding, structured errors, and risk-summary flows
- deterministic mock scoring rule documentation
- product, workflow, ethics, architecture, and validation planning documents
- dashboard, triage, and risk-summary workflow design for human review positioning
- risk register and pilot-readiness constraints

## What The Current MVP Demonstrates

- a user can submit a structured screening and receive a reproducible mock risk category
- the system can display explanation factors, missing-data caveats, and recommended next actions
- dashboard and triage views can reflect submitted demo records
- the repository clearly states that outputs are non-diagnostic and require human review
- major safety, privacy, bias, and workflow risks are documented even though not yet fully mitigated

## What Has Not Yet Been Validated

- no approved retrospective or prospective clinical dataset has been reviewed
- no sensitivity, specificity, calibration, or subgroup-performance analysis has been run on real data
- no pilot-site workflow simulation with named clinical reviewers has been captured in this repository
- no authentication, persistent audit trail, or production privacy controls have been implemented yet
- no formal incident drill or downtime exercise has been run

## Key Findings

### Strengths

- deterministic rules make mock outputs inspectable and reproducible
- the workflow is explicit about human review, escalation, and non-diagnostic positioning
- documentation is strong enough for stakeholder orientation and scoped pilot planning conversations

### Limitations

- current evidence is product and workflow evidence, not clinical performance evidence
- in-memory storage and missing access control prevent any live-use claim
- the explanation layer is only as credible as the underlying mock rules and should not be presented as validated clinical reasoning

## Risk Implications

- reviewers must not infer model effectiveness from polished UI behavior
- any live pilot remains blocked on privacy, access control, audit persistence, governance, and dataset-backed validation work
- urgent or high-risk workflow claims require site-specific escalation review before real deployment

## Decision

MindMap Care can continue with:

- internal demos
- partner workflow walkthroughs
- technical architecture reviews
- pilot-readiness planning

MindMap Care should not yet proceed to:

- live screening with identifiable patient data
- claims of validated model performance
- unsupervised clinical or outreach deployment

## Next Validation Actions

- obtain or define an approved evaluation dataset pathway
- run structured clinician review of sample explanations and triage actions
- define minimum acceptable safety and workflow thresholds
- implement authentication, audit persistence, and retention controls required for pilot data handling
- prepare the next validation summary after the first clinician review cycle or model/ruleset change
